The trademark application XENOPHA was filed by MECCELLIS BIOTECH, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on March 12, 2020, and it was registered by office on June 19, 2020 without any oppositions.
It was designated 'Basic Application' for International Application 1562836 at the World Intellectual Property Organization (WIPO).
The application was filed in French (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 6, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Biological and surgical implants
Biological implants for use in breast, thoracic, digestive, pelvic and plastic surgery
Biological prostheses for use in the repair, regeneration or strengthening of human tissue
Acellular matrices for use in surgery
Biological tissue matrices for use in the repair, regeneration or strengthening of human tissue.
The mark was filed in class 42 with following description of goods:
Research and development of new products in the field of medical devices, biomaterials and pharmaceuticals
Research and development of new products in the field of biological and surgical implants
Surgical and medical research
Medical and surgical research relating to the repair, regeneration and strengthening of tissue
Tissue and cell engineering
Research in the field of reconstructive plastic surgery and repair of damaged or ruptured soft tissue membranes.